SMA Combination denied for failing step therapy by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for sma combination are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Applies Step Therapy to Combination SMA Therapy

Step therapy — sometimes called "fail-first" — requires that a patient try one or more preferred or lower-cost treatments before the plan will authorize the requested therapy. For SMA combination treatment, BCBS may require documented use of a single disease-modifying agent (typically the plan's preferred formulary agent for SMA) before approving a second agent to be added. A step-therapy denial means the plan's records do not show a completed required prior step, or the documentation of that prior step was not included in the authorization request.

## Why This Denial Is Appealable

Step-therapy requirements are subject to exception in most states and under federal guidance when: (1) the required prior step was already completed and the documentation simply was not submitted, (2) the required step agent is contraindicated or not labeled for this patient's SMA type or age group, (3) the patient's clinical condition makes delay medically dangerous, or (4) the patient was already stable on the requested regimen before the plan's step requirement applied. Many states have enacted step-therapy reform laws that set specific grounds for mandatory exceptions.

## Federal Appeal Framework

• Step-therapy exception request: The first step is a formal exception. The prescriber must document which exception ground applies and provide supporting clinical evidence.
• Internal appeal (ACA §2719): If the exception is denied, file a Level 1 internal appeal with full documentation. BCBS must respond within plan-mandated timeframes.
• External review: After a final adverse determination, the federal independent external review window is generally four months from the adverse determination letter date; confirm the exact deadline on that letter.
• State step-therapy law: Check your state's step-therapy reform law (many states have enacted these since 2017). Your state insurance commissioner can advise on applicable protections if BCBS is a fully-insured plan.
• ERISA §503: For employer self-funded plans, the full-and-fair review requirement applies.

## Documentation to Gather

1. Prior step completion records: If a required prior agent was already tried, gather the prescribing records, pharmacy dispensing records, and dates with documented clinical response or reason for discontinuation. 2. Exception basis documentation: Your prescriber's signed letter explaining which exception ground applies. Common grounds: - Prior step agent is not labeled for this patient's SMA type (cite the FDA label). - Prior step agent was tried and produced inadequate response (document dates and outcome). - Clinical urgency makes further delay medically dangerous (document current functional trajectory). 3. Genetic and diagnostic confirmation: SMA type, SMN copy number, and current functional status. 4. Functional trajectory: Current and recent motor function, respiratory, and nutritional status with trend documentation. 5. Prescriber medical-necessity letter: Detailed letter tying all clinical evidence to the specific exception criteria.

## Criteria-Mapping Structure

Obtain BCBS's step-therapy criteria for SMA combination therapy. For each step requirement:

| Step Requirement | Status | Evidence | |---|---|---| | Required prior agent (per plan policy) | Completed / Exception applies | Rx records, dates: ___ to ___ | | Duration of required prior trial | Met / Waived | Dispensing records | | Documented response or failure | Inadequate response / contraindicated | Prescriber note, date: ___ | | Exception ground (if not completed) | State which applies | Prescriber letter, date: ___ |

Address every step in the table. If a step was completed before coverage under this plan, include records from the prior plan or prescriber.